Showing 761 - 780 results of 121,825 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.13s Refine Results
  1. 761
  2. 762
  3. 763
  4. 764
  5. 765
  6. 766
  7. 767
  8. 768
  9. 769
  10. 770

    NAC prevents VMH GI neuron activation by decreased glucose. by Xavier Fioramonti (371172)

    Published 2013
    “…(B) Percentage of VMH GI neurons from S<sup>3</sup>S or I<sup>3</sup>S rats pre-treated or not with NAC which depolarized in response to a 2.5–0.7 mM glucose decrease quantified using changes in FLIPR-MPD fluorescence intensity. *: p<0.05 (Two-way ANOVA; group differences were determined by One-Way ANOVA followed by Bonferoni post-hoc test).…”
  11. 771
  12. 772

    Hematopoietic potential decreases in ESC with down-regulation of junction molecules. by Basha L. Stankovich (207031)

    Published 2011
    “…CD45 expression was analyzed flow cytometrically using anti-CD45 conjugated to PerCP-Cy5.5. Non-viable cells were excluded based on DAPI fluorescence. …”
  13. 773

    Loss of Cntnap2 decreases specifically stabilization of new spines. by Amos Gdalyahu (3213810)

    Published 2015
    “…<p><b>a.</b> From left to right: Chronic imaging through a cranial window of L5 pyramidal neuron. …”
  14. 774
  15. 775

    Wnt5a expressing tumors demonstrate a decrease in markers of the basal tumor subtype. by Stephanie L. Easter (662168)

    Published 2014
    “…Values are means +/− standard error (n = 6 MMTV-Wnt1, 3 fields per tumor; n = 5 MMTV-Wnt1;MMTV-Wnt5a, 3 fields per tumor). MMTV-Wnt1;MMTV-Wnt5a tumors demonstrated a significant decrease in K6-expressing cells as measured by T-test (* = p<0.05).…”
  16. 776
  17. 777
  18. 778
  19. 779
  20. 780

    Image 5_Behavioral and biochemical changes associated with the analgesic effects of (2R,6R)-hydroxynorketamine alone and in combination with meloxicam following disk puncture in mi... by Vaskar Das (21529538)

    Published 2025
    “…Our finding supports further study of the clinical potential of (2R,6R)-Hydroxynorketamine as a non-opioid analgesic for discogenic back pain.…”